Sichuan Dowell Science and Technology Past Earnings Performance
Past criteria checks 1/6
Sichuan Dowell Science and Technology's earnings have been declining at an average annual rate of -13.7%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 13.3% per year. Sichuan Dowell Science and Technology's return on equity is 0.7%, and it has net margins of 4.3%.
Key information
-13.7%
Earnings growth rate
-13.8%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 13.3% |
| Return on equity | 0.7% |
| Net Margin | 4.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve
May 01
What Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) 36% Share Price Gain Is Not Telling You
Mar 08Returns On Capital Signal Tricky Times Ahead For Sichuan Dowell Science and Technology (SZSE:300535)
Feb 26Revenue & Expenses BreakdownBeta
How Sichuan Dowell Science and Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 767 | 33 | 129 | 47 |
| 31 Dec 23 | 725 | 28 | 125 | 42 |
| 30 Sep 23 | 647 | 21 | 117 | 37 |
| 30 Jun 23 | 569 | 6 | 111 | 31 |
| 31 Mar 23 | 520 | -3 | 104 | 29 |
| 01 Jan 23 | 510 | -2 | 103 | 30 |
| 30 Sep 22 | 530 | 18 | 105 | 39 |
| 30 Jun 22 | 580 | 40 | 107 | 40 |
| 31 Mar 22 | 619 | 61 | 110 | 40 |
| 01 Jan 22 | 630 | 66 | 113 | 42 |
| 30 Sep 21 | 655 | 80 | 93 | 44 |
| 30 Jun 21 | 625 | 86 | 91 | 44 |
| 31 Mar 21 | 542 | 74 | 85 | 42 |
| 31 Dec 20 | 470 | 57 | 85 | 37 |
| 30 Sep 20 | 422 | 45 | 106 | 36 |
| 30 Jun 20 | 375 | 24 | 107 | 38 |
| 31 Mar 20 | 372 | 24 | 107 | 39 |
| 31 Dec 19 | 396 | 39 | 105 | 39 |
| 30 Sep 19 | 354 | 35 | 109 | 31 |
| 30 Jun 19 | 355 | 40 | 103 | 27 |
| 31 Mar 19 | 361 | 42 | 106 | 25 |
| 31 Dec 18 | 356 | 41 | 102 | 24 |
| 30 Sep 18 | 364 | 45 | 90 | 25 |
| 30 Jun 18 | 349 | 46 | 80 | 32 |
| 31 Mar 18 | 334 | 46 | 82 | 25 |
| 31 Dec 17 | 333 | 52 | 83 | 20 |
| 30 Sep 17 | 335 | 61 | 81 | 14 |
| 30 Jun 17 | 317 | 59 | 92 | 0 |
| 31 Mar 17 | 312 | 61 | 85 | 0 |
| 31 Dec 16 | 299 | 58 | 83 | 0 |
| 30 Sep 16 | 288 | 57 | 78 | 0 |
| 30 Jun 16 | 282 | 54 | 76 | 0 |
| 31 Mar 16 | 270 | 49 | 73 | 0 |
| 31 Dec 15 | 275 | 48 | 72 | 0 |
| 31 Dec 14 | 270 | 40 | 74 | 0 |
| 31 Dec 13 | 267 | 34 | 64 | 0 |
Quality Earnings: 300535 has a large one-off loss of CN¥42.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 300535 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300535's earnings have declined by 13.7% per year over the past 5 years.
Accelerating Growth: 300535 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 300535 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.8%).
Return on Equity
High ROE: 300535's Return on Equity (0.7%) is considered low.